Do Han Kim

Do Han Kim

Auto-generated profile, based on publicly available information

Do Han Kim

Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
LNLuis Miguel Nieto
Luis Miguel Nieto
JMJohn Martinez
John Martinez
SNSharon I. Narvaez
Sharon I. Narvaez
DKDonghyun Ko
Donghyun Ko
DKDo Han Kim
Do Han Kim
SCSaurabh Chawla
Saurabh Chawla
INTRODUCTION: Type 2 diabetes mellitus (T2DM) can lead to structural pancreatic changes potentially predisposing to acute pancreatitis (AP), increasing morbidity and mortality. Scarce data exist on the outcomes of AP in patients with T2DM who are taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The study aim was to evaluate AP outcome and all-cause mortality in patients with T2DM using GLP-1 RAs. METHODS: A retrospective cohort study was performed using population-based data from the TriNetX platform. Patients with T2DM receiving GLP-1 RAs drugs (semaglutide, liraglutide, dulaglutide, and tirzepatide) between January 1, 2015, and October 31, 2023, were included. This patient cohort was matched with patients with T2DM who did not receive GLP-1 RAs according to age, demographics, comorbidities, and medication by using 1:1 propensity matching. To avoid confounding, etiologies of AP including alcohol-induced, trauma, biliary, class Ia drug-induced, hypertriglyceridemia, and postendoscopic retrograde cholangiopancreatography were excluded from both cohorts. Primary outcomes were risk of developing AP, need for parenteral nutrition, systemic complications (sepsis, systemic inflammatory response syndrome, shock, mechanical ventilation, acute kidney injury), and local pancreatic complications. The secondary outcome was all-cause mortality. Cox proportional hazards models were used to estimate hazard ratios (HRs). RESULTS: A total of 740,370 patients with T2DM were identified with 29,423 on GLP-1 RAs; 20,459 of those 29,423 (mean [SD] age, 58.1 [11.9] years; 10,190 [49.85%] female) were matched with 20,459 individuals (mean [SD] age, 57.5 [13.9] years; 10,301 [50.35%] female) who did not take GLP-1 RAs. The GLP-1 RAs group had lower risk of complicated pancreatitis (HR 0.32; 95% confidence interval [CI] 0.14–0.74), parenteral nutrition needs (HR 0.28; 95% CI 0.09–0.83), sepsis (HR 0.71; 95% CI 0.59–0.84), acute kidney injury (HR 0.54; 95% CI 0.49–0.60), shock (HR 0.52; 95% CI 0.36–0.75), and mechanical ventilation support during admission (HR 0.23; 95% CI 0.16–0.33) compared with the non-GLP-1 RAs group. In addition, all-cause mortality was decreased in the GLP-1 agonist group compared with the non-GLP-1 agonist group (HR 0.45; 95% CI 0.41–0.49). Important to note that the GLP-1 RAs group had a tendency of lower risk of uncomplicated pancreatitis (HR 0.71; 95% CI 0.49–1.01) but without statistically significant result. No difference was found between the groups in risk of developing systemic inflammatory response syndrome if it occurs. DISCUSSION: GLP-1 RAs use does not increase AP risk is associated with lower complications in those who developed AP and linked with lower all-cause mortality in patients with T2DM. Prospective studies are needed to determine the mechanisms behind these findings.

31 March 2022 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
DKDo Han Kim
Do Han Kim
Somashekar KrishnaSomashekar Krishna
Somashekar Krishna
ECEmmanuel Coronel
Emmanuel Coronel
PKPaul Kroner
Paul Kroner
HWHerbert C. Wolfsen
Herbert C. Wolfsen
JCJuan E. Corral
Juan E. Corral
Background/Aims: Endoscopic visualization of the microscopic anatomy can facilitate the real-time diagnosis of pancreatobiliary disorders and provide guidance for treatment. This study aimed to review the technique, image classification, and diagnostic performance of confocal laser endomicroscopy (CLE).Methods: We conducted a systematic review of CLE in pancreatic and biliary ducts of humans, and have provided a narrative of the technique, image classification, diagnostic performance, ongoing research, and limitations.Results: Probe-based CLE differentiates malignant from benign biliary strictures (sensitivity, ≥89%; specificity, ≥61%). Needlebased CLE differentiates mucinous from non-mucinous pancreatic cysts (sensitivity, 59%; specificity, ≥94%) and identifies dysplasia. Pancreatitis may develop in 2-7% of pancreatic cyst cases. Needle-based CLE has potential applications in adenocarcinoma, neuroendocrine tumors, and pancreatitis (chronic or autoimmune). Costs, catheter lifespan, endoscopist training, and interobserver variability are challenges for routine utilization.Conclusions: CLE reveals microscopic pancreatobiliary system anatomy with adequate specificity and sensitivity. Reducing costs and simplifying image interpretation will promote utilization by advanced endoscopists.

30 April 2025 in The American Journal of Medicine
Verified
Journal Article
Closed access
DKDo Han Kim
Do Han Kim
DKDonghyun Ko
Donghyun Ko
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
GHGlenn Jun Kit Ho
Glenn Jun Kit Ho
FTFaith Xin Ning Tan
Faith Xin Ning Tan
KWKarn Wijarnpreecha
Karn Wijarnpreecha

24 May 2025 in Pancreatology
Verified
Journal Article
Closed access
PDPojsakorn Danpanichkul
Pojsakorn Danpanichkul
YPYanfang Pang
Yanfang Pang
DKDonghee Kim
Donghee Kim
TAThanida Auttapracha
Thanida Auttapracha
SCShu-Yen Emily Shu-Yen Chan
Shu-Yen Emily Shu-Yen Chan
KWKarn Wijarnpreecha
Karn Wijarnpreecha

27 December 2025 in Liver International
Verified
Journal Article
Closed access
DKDo Han Kim
Do Han Kim
DKDonghyun Ko
Donghyun Ko
VCVincent Chen
Vincent Chen
JPJose A. Porres
Jose A. Porres
CACarlos Elizondo Alatorre
Carlos Elizondo Alatorre
KWKarn Wijarnpreecha
Karn Wijarnpreecha

15 June 2023 in Advances in Medical Sciences
Verified
Journal Article
Closed access
DKDo Han Kim
Do Han Kim
FLFrank J. Lukens
Frank J. Lukens
DKDonghyun Ko
Donghyun Ko
PKPaul Kroner
Paul Kroner
MSMiguel Salazar
Miguel Salazar
PAPedro Palacios Argueta
Pedro Palacios Argueta